Project Grant 2036294
Award Date
2/15/21
Completion Date
1/31/22
Dollars Obligated
$256K
Funding Federal Agency
National Science Foundation
Awarding Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Valhalla, NY 10595, USA
Similar Awards
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
Phenotarget Biosciences Inc. was awarded a $255,473 Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The grant supports discovery and development of macrocyclic peptide inhibitors of SARS-CoV-2 spike protein for the treatment of COVID-19 from July 1, 2021 through March 31, 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in...
The National Science Foundation awarded Fibrosix Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of March 1, 2021 through August 31, 2021. The grant funding supports Fibrosix's "SBIR PHASE I: QUIETING SYSTEMIC HYPER-INFLAMMATION (COVID-19)" project. Specifically, the grant will enable Fibrosix to conduct research towards developing technologies or techniques to reduce excessive inflammation in response to COVID-19 and future...
This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...
This $247,457 National Science Foundation project grant funded research on coupling COVID-19 respiratory droplet adsorption and photocatalysis through metal organic frameworks. The grant was awarded to Framergy Inc. on June 15, 2021 under the Engineering (47.041) federal grant program. The objective was to develop materials and techniques to capture and deactivate SARS-CoV-2 virus particles through the end date of November 30, 2021. The Engineering program seeks to improve quality of life and...
Nellone Therapeutics Inc. received a $242k National Science Foundation SBIR Phase I Project Grant under the Engineering federal grant program to develop regulation of hyperinflammation and cell survival therapies for severe lung tissue damage from viral infections such as COVID-19. The award period is April 1, 2021 through March 31, 2022. As part of NSF's mission to promote innovation and U.S. competitiveness, this SBIR Phase I grant supports Nellone's proposed research to advance a NELL1/NV1...
The National Science Foundation awarded Medchem Partners LLC a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of August 1, 2021 through July 31, 2022. The grant funds the development of novel inhaled nitric oxide therapy for pulmonary treatments related to COVID-19. The Engineering program seeks to improve quality of life and economic strength through engineering research and innovation. This award supports Medchem Partners' work advancing new...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...